Aeon BiopharmaAEON
13F holders, Q4 2025 (December 31)22holders +1
4new positions
3sold out
1famous investor
$0.68avg. 13F price*
At the end of Q4 2025, 22 institutions reported holding Aeon Biopharma Inc. (AEON) in their 13F filings, up 1 from Q3 2025. 4 opened new positions and 3 sold out. The largest holders were Dauntless Investment Group, LLC ($1.3M), Vanguard Group Inc. ($110K) and Geode Capital Management, LLC ($66K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $44K |
| Exits | 3 | $23K |
All 13F filers, Q3 2025 → Q4 2025: 1,106,602 shares bought and 28,020 shares sold, net +1,078,582 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Dauntless Investment Group, LLC | 4.87% | Add +89.5% | 2,131,852 | $1.3M |
| Vanguard Group Inc. | 0.00% | Add +1.8% | 100,333 | $110K |
| Geode Capital Management, LLC | 0.00% | Add +27.8% | 60,134 | $66K |
| XTX Topco Ltd | 0.00% | Add +251.8% | 56,852 | $63K |
| Blue Owl Capital Holdings LP | 0.01% | Add +2.5% | 43,395 | $48K |
| Laird Norton Wetherby Trust Company, LLC | 0.00% | New | 15,000 | $17K |
| Two Sigma Securities, LLC | 0.00% | New | 13,180 | $14K |
| Citadel Advisors | 0.00% | New | 11,642 | $13K |
| UBS Group AG | 0.00% | Add +239.9% | 4,052 | $4K |
| BlackRock, Inc. | 0.00% | No change | 2,834 | $3K |
| Bank of America Corp. | 0.00% | Add +0.3% | 2,382 | $3K |
| Wolff Wiese Magana LLC | 0.00% | Add +746.3% | 567 | $624 |
| Dupont Capital Management Corp. | 0.00% | No change | 170 | $187 |
| Morgan Stanley | 0.00% | No change | 150 | $165 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.9% | 105 | $116 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 100 | $110 |
| GHP Investment Advisors, Inc. | 0.00% | No change | 95 | $105 |
| Wells Fargo & Company | 0.00% | No change | 90 | $99 |
| MAI Capital Management | 0.00% | No change | 58 | $64 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 33 | $36 |
| Meteora Capital, LLC | 0.00% | New | 4 | $4 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is AEON's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.